Peter Heerma is CHIEF COMMERCIAL OFFICER of Travere Therapeutics, Inc.. Currently has a direct ownership of 125,066 shares of TVTX, which is worth approximately $2.75 Million. The most recent transaction as insider was on Feb 02, 2021, when has been sold 563 shares (Common Stock) at a price of $30.75 per share, resulting in proceeds of $17,312. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
15.85% 3M change
25.69% 12M change
Total Value Held $2.75 Million

Peter Heerma Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
SELL
Open market or private sale
$17,312 $30.75 p/Share
563 Reduced 0.97%
57,657 Common Stock
Jan 21 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 20.49%
58,220 Common Stock
Oct 05 2020
SELL
Open market or private sale
$42,338 $19.35 p/Share
2,188 Reduced 4.91%
42,329 Common Stock
Oct 02 2020
SELL
Open market or private sale
$41,353 $18.9 p/Share
2,188 Reduced 4.68%
44,517 Common Stock
PH

Peter Heerma

CHIEF COMMERCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on TVTX

Follow Travere Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX